Compounds > imatinib mesylate
Page last updated: 2024-09-03

imatinib mesylate and Leukocytopenia

imatinib mesylate has been researched along with Leukocytopenia in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (83.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Daniels, CE; Gabor, E; Lasky, JA; Limper, AH; Mieras, K; Schroeder, DR1
Jin, ML; Shen, L1
Bergmann, JF; Bouscary, D; Ferrand, H; Mouly, S; Tamburini, J1
Higashi, T; Kubota, A; Matsuura, A; Mizobe, T; Morimoto, H; Mouri, F; Ohta, T; Sugito, M; Tanaka, Y; Tsukada, J1
Azuma, M; Higuchi, K; Katada, C; Koizumi, W; Nakatani, K; Nishimura, K; Saigenji, K; Sasaki, T; Shimoda, T; Tanabe, S1
Bosi, E; Davalli, AM; Folli, F; Galimberti, G; Pastore, M1

Trials

1 trial(s) available for imatinib mesylate and Leukocytopenia

ArticleYear
Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results.
    American journal of respiratory and critical care medicine, 2010, Mar-15, Volume: 181, Issue:6

    Topics: Aged; Anemia; Benzamides; Disease Progression; Double-Blind Method; Dyspnea; Feasibility Studies; Female; Follow-Up Studies; Gastrointestinal Diseases; Hematoma, Subdural; Humans; Idiopathic Pulmonary Fibrosis; Imatinib Mesylate; Leukopenia; Male; Middle Aged; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Respiratory Function Tests; Survival Analysis; Treatment Outcome

2010

Other Studies

5 other study(ies) available for imatinib mesylate and Leukocytopenia

ArticleYear
[Imatinib mesylate alone for refractory advanced gastrointestinal stromal tumor].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2004, Volume: 26, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Edema; Female; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Leukopenia; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Peritoneal Neoplasms; Piperazines; Pyrimidines; Remission Induction; Survival Rate

2004
Listeria monocytogenes meningitis following imatinib mesylate-induced monocytopenia in a patient with chronic myeloid leukemia.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Dec-01, Volume: 41, Issue:11

    Topics: Anti-Bacterial Agents; Benzamides; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukopenia; Meningitis, Listeria; Middle Aged; Monocytes; Piperazines; Pyrimidines

2005
[Generalized erythema triggered by a rapid decrease of basophils in chronic myeloid leukemia treated with imatinib].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2005, Volume: 46, Issue:11

    Topics: Antineoplastic Agents; Basophils; Benzamides; Erythema; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocytosis; Leukopenia; Middle Aged; Piperazines; Pyrimidines; Severity of Illness Index

2005
[A gastric stromal tumor (GIST) with a prolonged partial response to a reduced dose of imatinib mesilate].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:7

    Topics: Aged; Anemia; Antineoplastic Agents; Benzamides; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Leukopenia; Liver Neoplasms; Piperazines; Pyrimidines; Stomach Neoplasms

2006
Paraneoplastic insulin resistance syndrome in advanced aggressive fibromatosis (desmoid tumor) treated by imatinib mesylate.
    Diabetes care, 2006, Volume: 29, Issue:9

    Topics: Anemia; Benzamides; Female; Fibromatosis, Aggressive; Humans; Hypoglycemic Agents; Imatinib Mesylate; Insulin; Insulin Resistance; Leukopenia; Middle Aged; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Treatment Outcome

2006